SAN DIEGO, Feb. 3, 2026 — Illumina (NASDAQ: ILMN) today announced a sequencing agreement with the San Diego Zoo Wildlife Alliance (SDZWA)’s Frozen Zoo®. The 50-year-old biobank is the world’s most ...
Illumina (NasdaqGS:ILMN) expanded its Alliance for Genomic Discovery by adding Regeneron Genetics Center. The partners launched a large-scale program to pair whole genome sequences with proteomic data ...
6d
Why Illumina (ILMN) Is Up 14.3% After Launching TruPath Genome And Expanding Rare-Disease Sequencing
In late February 2026, Illumina, Inc. launched its TruPath Genome whole‑genome solution and expanded clinical sequencing services, including supporting Florida State University’s new pediatric rare ...
40% increase in output to 35 billion reads, up to Q70 quality scores, improved turnaround time, and staggered starts are among the updates to be rolled out on all NovaSeq X systems, advancing ...
Illumina, Inc. (NASDAQ: ILMN) today announced that Illumina Laboratory Services, Illumina's CLIA-certified laboratory, is providing clinical sequencing and interpretation services to the new ...
(NASDAQ: ILMN), and Nashville Biosciences, LLC (NashBio), today announced two advancements in scale and depth of the Alliance ...
Element Biosciences created a high-throughput benchtop device that can deliver a whole genome for $100 – half the price of ...
TruPath™ Genome offers more complete genome, with the simplest sample to sequencer workflow, and the new AGBT data demonstrates its accuracy in detecting rare genetic diseases40% increase in output to ...
The collaborations will provide Illumina's customers with workflows for genomic disease characterization and spatial mapping.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results